AFP
PFE icon

Ausdal Financial Partners’s Pfizer PFE Stock Holding History

Ausdal Financial Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Sell
44,198
-11,480
-21% -$306K 0.06% 323
2025
Q4 		$1.39M Buy
55,678
+12,277
+28% +$310K 0.06% 287
2025
Q3 		$1.11M Buy
43,401
+15,966
+58% +$394K 0.05% 342
2025
Q2 		$665K Sell
27,435
-1,221
-4% -$28.5K 0.04% 354
2025
Q1 		$726K Buy
28,656
+2,998
+12% +$78.5K 0.05% 295
2024
Q4 		$681K Buy
25,658
+10,262
+67% +$278K 0.06% 272
2024
Q3 		$446K Buy
15,396
+429
+3% +$12.5K 0.05% 336
2024
Q2 		$419K Buy
14,967
+982
+7% +$27K 0.04% 319
2024
Q1 		$388K Buy
13,985
+939
+7% +$26.1K 0.05% 321
2023
Q4 		$376K Sell
13,046
-6,681
-34% -$202K 0.05% 305
2023
Q3 		$654K Sell
19,727
-910
-4% -$32.2K 0.09% 202
2023
Q2 		$757K Sell
20,637
-176
-0.8% -$6.85K 0.1% 190
2023
Q1 		$849K Sell
20,813
-796
-4% -$34.4K 0.12% 182
2022
Q4 		$1.11M Sell
21,609
-24
-0.1% -$1.15K 0.16% 152
2022
Q3 		$947K Buy
21,633
+863
+4% +$41.9K 0.15% 166
2022
Q2 		$1.09M Sell
20,770
-642
-3% -$32.7K 0.16% 161
2022
Q1 		$1.11M Sell
21,412
-4,253
-17% -$221K 0.15% 171
2021
Q4 		$1.52M Sell
25,665
-1,118
-4% -$55.4K 0.2% 139
2021
Q3 		$1.15M Sell
26,783
-814
-3% -$36.1K 0.17% 163
2021
Q2 		$1.08M Buy
27,597
+1,151
+4% +$44.8K 0.16% 165
2021
Q1 		$958K Buy
26,446
+2,456
+10% +$87.2K 0.16% 160
2020
Q4 		$883K Sell
23,990
-2,101
-8% -$77.1K 0.17% 149
2020
Q3 		$908K Buy
26,091
+7,747
+42% +$272K 0.22% 125
2020
Q2 		$569K Buy
18,344
+1,972
+12% +$67K 0.19% 130
2020
Q1 		$560K Buy
16,372
+3,622
+28% +$123K 0.2% 125
2019
Q4 		$455K Sell
12,750
-2,220
-15% -$79.1K 0.13% 194
2019
Q3 		$510K Sell
14,970
-2,660
-15% -$96.7K 0.18% 150
2019
Q2 		$649K Sell
17,630
-140
-0.8% -$5.56K 0.25% 107
2019
Q1 		$716K Buy
17,770
+526
+3% +$21.1K 0.29% 86
2018
Q4 		$714K Sell
17,244
-8,892
-34% -$369K 0.35% 72
2018
Q3 		$1.09M Buy
26,136
+165
+0.6% +$6.35K 0.31% 94
2018
Q2 		$894K Buy
25,971
+3,781
+17% +$129K 0.28% 111
2018
Q1 		$747K Sell
22,190
-1,067
-5% -$36.7K 0.26% 113
2017
Q4 		$799K Sell
23,257
-1,347
-5% -$45.9K 0.29% 108
2017
Q3 		$833K Buy
24,604
+1,599
+7% +$51.4K 0.33% 85
2017
Q2 		$733K Buy
23,005
+5,108
+29% +$161K 0.31% 87
2017
Q1 		$581K Sell
17,897
-117
-0.6% -$3.69K 0.26% 98
2016
Q4 		$555K Buy
18,014
+4,198
+30% +$128K 0.26% 103
2016
Q3 		$444K Sell
13,816
-321
-2% -$10.7K 0.22% 126
2016
Q2 		$472K Buy
14,137
+263
+2% +$8.39K 0.24% 110
2016
Q1 		$390K Buy
13,874
+1,347
+11% +$38.5K 0.22% 126
2015
Q4 		$384K Buy
+12,527
New +$394K 0.19% 122

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ausdal Financial Partners's PFE Position: Q1 2026 in Review

Ausdal Financial Partners reduced its Pfizer (PFE) stake by 21% in Q1 2026, selling an estimated $306K and leaving 44,198 shares worth $1.24M. The position accounts for 0.06% of the portfolio, ranked #323.

Ausdal Financial Partners first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.52M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ausdal Financial Partners held 44,198 shares of Pfizer worth $1.24M as of Q1 2026.
  • Ausdal Financial Partners sold 11,480 Pfizer shares in Q1 2026, an estimated $306K.
  • Pfizer made up 0.06% of Ausdal Financial Partners's portfolio in Q1 2026, its #323 holding.
  • Ausdal Financial Partners first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • Ausdal Financial Partners's Pfizer position peaked at $1.52M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.